Loading...
Prospera Life Sciences Private Limited — Sofosbuvir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #12 for Sofosbuvir · $94.3K export value · DGFT Verified
Prospera Life Sciences Private Limited is the #12 Indian exporter of Sofosbuvir with $94.3K in export value and 21 verified shipments. Prospera Life Sciences Private Limited holds a 0.2% market share in Sofosbuvir exports across 4 countries. The company exports 6 pharmaceutical products worth $412.0K across 2 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $56.4K | 9 | 59.8% |
| CAMBODIA | $21.1K | 4 | 22.3% |
| LAO | $8.6K | 6 | 9.1% |
| MALAYSIA | $8.1K | 1 | 8.6% |
| LAO PEOPLE'S DEMOCRATIC REPUBLIC | $166 | 1 | 0.2% |
Prospera Life Sciences Private Limited exports Sofosbuvir to 5 countries. The largest destination is THAILAND accounting for 59.8% of Prospera Life Sciences Private Limited's Sofosbuvir shipments, followed by CAMBODIA (22.3%) and LAO (9.1%). These destinations reflect Prospera Life Sciences Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STR INTERNATIONAL TRADING CO LTD | THAILAND | $64.7K | 10 |
| STR INTERNATIONAL TRADING CO LIMITED | THAILAND | $12.7K | 3 |
| MR. NORLADETH THAMMAVONG | LAO | $8.6K | 6 |
| WORLD ASIA LOGISTICS (M) SDN BHD | MALAYSIA | $8.1K | 1 |
| AS PER INVOICE | LAO PEOPLE'S DEMOCRATIC REPUBLIC | $166 | 1 |
Prospera Life Sciences Private Limited supplies Sofosbuvir to 5 buyers globally. The largest buyer is STR INTERNATIONAL TRADING CO LTD (THAILAND), followed by STR INTERNATIONAL TRADING CO LIMITED (THAILAND) and (LAO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $18.1M worth of Sofosbuvir through 1,341 shipments from 150 suppliers to 113 countries, serving 377 buyers globally. Prospera Life Sciences Private Limited contributes $94.3K to this total, accounting for 0.2% of India's Sofosbuvir exports. Prospera Life Sciences Private Limited ships Sofosbuvir to 5 countries through 5 buyers.
Prospera Life Sciences Private Limited's average Sofosbuvir shipment value is $4.5K per consignment, based on 21 shipments totaling $94.3K. The largest destination is THAILAND (59.8% of Prospera Life Sciences Private Limited's Sofosbuvir exports).
Prospera Life Sciences Private Limited ranks #12 among 150 Indian Sofosbuvir exporters with a 0.2% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($9.9M), HETERO LABS LIMITED ($5.3M), NATCO PHARMA LIMITED ($800.0K). Prospera Life Sciences Private Limited processed 21 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SOFOSBUVIR 400 MG AND VELPATASVIR 100 MG | $37.8K | 4 |
| SOFOSBUVIR 400 MG AND VELPATASVIR 100 MGTABLETS 1 28 BOTTLE VELASOF BATCH NO HH2210510 Mfg 10 2022 | $16.0K | 3 |
| SOFOSBUVIR AND VELPATASVIR TABLETS 400 M | $15.6K | 2 |
| SOFOSBUVIR 400 MG & VELPATASVIR 100 MG T | $11.0K | 2 |
| BRAND NAME : MYHEPALL MOLECULE NAME : SOFOSBUVIR AND VELPATASVIR TABLETS 400 MG/100 MG 1*28 BOTTLE BATCH NO.: 3234237 M | $8.3K | 4 |
| LEDIPASVIR 90 MG AND SOFOSBUVIR 400 MG T | $3.3K | 2 |
| SOFOSBUVIR TABLETS 400 MG 1*28 BOTTLE | $1.7K | 1 |
| BRAND NAME : MYHEP MOLECULE NAME:SOFOSBUVIR TABLETS 400 MG 1*28 BOTTLE BATCH NO.: 3208180 Mfg: 04/2024 Exp: 03/2027 COMP | $322 |
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | LEOWIN HEALTHCARE LLP | $140.8K | 70 | 3 | $2.0K |
| 11 | GALAXY SUPER SPECIALITY | $124.8K | 38 | 7 | $3.3K |
| 12 | PROSPERA LIFE SCIENCES PRIVATE LIMITED ★ | $94.3K | 21 | 4 | $4.5K |
| 13 | DEVLIFE CORPORATION PRIVATE LIMITED | $91.7K | 3 | 1 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 357 | 26.6% |
| SAHAR AIR | 269 | 20.1% |
| DELHI AIR CARGO ACC (INDEL4) | 158 | 11.8% |
| Bombay Air | 126 | 9.4% |
| DELHI AIR | 79 | 5.9% |
| AHEMDABAD AIR | 68 | 5.1% |
| AHEMDABAD AIR ACC (INAMD4) | 50 | 3.7% |
| HYDERABAD ACC (INHYD4) | 39 | 2.9% |
Prospera Life Sciences Private Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Prospera Life Sciences Private Limited exports 6 products worth $412.0K. Beyond Sofosbuvir, top products include Lenvatinib, Velpatasvir, Sorafenib, Gefitinib, Cabozantinib. View the complete Prospera Life Sciences Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Sofosbuvir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Prospera Life Sciences Private Limited's Sofosbuvir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Prospera Life Sciences Private Limited
Full Company Profile →
6 products · $412.0K total trade · 2 categories
| 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONSOFOSBUVIR TABLETS 400 MG 1*28 BOTTLE (MYHEP ) BATCH NO. 3199170 MFG | $166 | 1 |
Prospera Life Sciences Private Limited exports 9 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOFOSBUVIR 400 MG AND VELPATASVIR 100 MG with 4 shipments worth $37.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
| $30.6K |
Prospera Life Sciences Private Limited ranks #12 among 150 Indian Sofosbuvir exporters. Average shipment value of $4.5K compared to the market average of $120.8K. The closest competitors by value are LEOWIN HEALTHCARE LLP and GALAXY SUPER SPECIALITY.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Prospera Life Sciences Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sofosbuvir. For current shipment-level data, contact TransData Nexus.